This three-part webinar series explores how cutting-edge AI, including foundation models, is being applied to drug discovery.
PARIS--(BUSINESS WIRE)--Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a research collaboration with Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), ...
Tres Alchemix, an AI biotech startup, has raised $4.4M in Series A funding to expand its predictive drug-design platform. With a new lab opening in Oxford, UK, the company aims to accelerate AI-driven ...
Neo-1 is the first model to unify de novo molecular generation and atomic-level structure prediction in a single model, by generating latent representations of whole molecules instead of predicting ...
Researchers headed by teams at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) and Memorial Sloan Kettering Cancer Center have developed what they describe as a ...
(RTTNews) - XtalPi (2228.HK) announced an expanded research collaboration with Pfizer (PFE) to develop a next-generation molecular modeling platform for drug discovery. The initiative aims to enhance ...
What is the process of oral drug absorption, and how has the Fa equation evolved? Oral drug absorption begins with administering a drug product, followed by a rapid disintegration process. The drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback